Stocks and securities in focus
Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Inc. | 0.220% | 2.815% | 9.995% | 28.759% | 9.565% | 132.447% | 167.754% |
Ocular Therapeutix Inc. | 2.560% | 0.500% | 14.893% | -5.874% | 34.032% | -50.230% | 148.850% |
Intra-Cellular Therapies Inc. | 2.480% | 1.639% | -8.824% | 6.713% | -4.908% | 90.418% | 444.337% |
Gritstone Oncology Inc | -1.880% | 8.748% | 10.797% | -57.948% | -58.854% | -89.738% | - |
Eli Lilly Corp. | 0.590% | 4.844% | 8.613% | 80.801% | 40.189% | 351.204% | 606.972% |
Cardiff Oncology Inc. | -6.570% | 1.084% | -19.877% | 109.027% | 148.100% | -49.380% | -6.714% |
Agenus Inc. | -1.970% | - | - | - | - | - | - |